Recent News

• 02.25.2025 - Milestone Pharmaceuticals In-Person and Virtual Commerical Event
• 02.25.2025 - Milestone Pharmaceuticals In-Person and Virtual Commerical Event
• 02.19.2025 - Milestone® Pharmaceuticals Notice of Allowance on New U.S. Patent for Etripamil
• 02.19.2025 - Milestone® Pharmaceuticals Notice of Allowance on New U.S. Patent for Etripamil
• 02.11.2025 - Milestone Pharmaceuticals to Host Commercial Launch Plan Investor Event in New York on February 25, 2025
• 02.11.2025 - Milestone Pharmaceuticals to Host Commercial Launch Plan Investor Event in New York on February 25, 2025
• 01.28.2025 - Milestone Pharmaceuticals Provides 2025 Corporate Outlook and Will Host Investor Event on February 25 in NYC
• 01.28.2025 - Milestone Pharmaceuticals Provides 2025 Corporate Outlook and Will Host Investor Event on February 25 in NYC
• 01.27.2025 - Robert Wills
• 01.27.2025 - Robert Wills

Recent Filings

• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.05.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.29.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.29.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.29.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.29.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.29.2025 - 4 Statement of changes in beneficial ownership of securities